Results 21 to 30 of about 1,855,990 (303)

Calcium Channel Blockers and Hypertension

Journal of Cardiovascular Pharmacology and Therapeutics, 2014
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of hypertension-related cardiovascular and renal diseases. In spite of these well-established concepts, hypertension remains poorly controlled worldwide. In order to improve BP control in patients with hypertension, several interventions have been proposed,
TOCCI, GIULIANO, BATTISTONI, ALLEGRA, PASSERINI, JASMINE, MUSUMECI, Maria Beatrice, FRANCIA, Pietro, FERRUCCI, Andrea, VOLPE, Massimo   +6 more
openaire   +3 more sources

Diltiazem for clozapine-induced generalized hyperhidrosis [PDF]

Mental Health Clinician, 2023
Background Clozapine can be associated with significant side effects and tolerability issues. Hyperhidrosis occurs less commonly and is unanticipated by clinicians because of clozapine's significant anticholinergic activity.
Kenton Emma M. PharmD, Zoellner Samantha M. PharmD Candidate, May 2024, Nelson Leigh Anne PharmD, BCPP   +2 more
doaj   +1 more source

Antiarrhythmic drug usage and prostate cancer: a population-based cohort study

Asian Journal of Andrology, 2018
Even though the relationship between antiarrhythmic drug usage and subsequent prostate cancer (PCa) risk has recently been highlighted, relevant findings in the previous literature are still inconsistent.
Li-Ting Kao, Chung-Chien Huang, Herng-Ching Lin, Chao-Yuan Huang   +3 more
doaj   +1 more source

Perbandingan derajat sindroma mata kering antara penggunaan calcium channel blocker dan non calcium channel blocker pada pasien hipertensi di RS PHC Surabaya [PDF]

, 2023
Latar belakang: Sindroma mata kering merupakan penyakit multifaktorial yang terjadi pada permukaan okular, ditandai dengan hilangnya homeostasis dari tear film yang dapat disertai dengan gangguan penglihatan.
Simon, Axela Elisabeth
core  

Pharmacological, Pharmacokinetic, and Clinical Properties of Benidipine Hydrochloride, a Novel, Long-Acting Calcium Channel Blocker

Journal of Pharmacological Sciences, 2006
.: Benidipine is a dihydropyridine-derived calcium channel blocker developed in Japan, with several unique mechanisms of action, that is, triple calcium channels (L, N, and T) blocking action with a membrane approach.
Kozo Yao, Ken Nagashima, Hiroyuki Miki
doaj   +1 more source

Calcium channel blockers and dementia [PDF]

British Journal of Pharmacology, 2013
Degenerative dementia is mainly caused by Alzheimer's disease and/or cerebrovascular abnormalities. Disturbance of the intracellular calcium homeostasis is central to the pathophysiology of neurodegeneration. In Alzheimer's disease, enhanced calcium load may be brought about by extracellular accumulation of amyloid‐β.
Nimmrich, V, Eckert, A
openaire   +3 more sources

Cost Analysis of Antihypertensive Therapy in the Hypertensive Patients

Journal of College of Medical Sciences-Nepal
Background Hypertension is an established chronic disease with a huge economic burden to society so choosing cost effective medication is essential. Several medications are available and the decision lies in the prescriber so the generation of evidence ...
Sabita Paudel, Sudeshana Adhikari, Tirtha Lal Upadhyaya, Nuwadatta Subedi   +3 more
doaj   +1 more source

Calcium Channel Blockers

Medical Clinics of North America, 1988
The calcium channel blockers initially were approved for the treatment of classical and variant angina pectoris. Recent studies indicate that these agents also are useful in such diverse conditions as pulmonary and systemic hypertension, hypertrophic cardiomyopathy, arrhythmias, asthma, Raynaud's syndrome, esophageal spasm, myometrial hyperactivity ...
openaire   +2 more sources

Phenytoin- and amlodipine-induced gingival overgrowth

Journal of Dental Sciences, 2012
Drug-induced gingival overgrowth is an adverse event associated with three types of drugs, i.e., anticonvulsants, immunosuppressants, and calcium-channel blockers.
Ching-Wen Chang, Chih-Jen Yang, Yu-Lin Lai   +2 more
doaj   +1 more source

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Knowledge of real‐world antihypertensive use is limited to prevalent hypertension, limiting our understanding of how treatment evolves and its contribution to persistently poor blood pressure control. We sought to characterize antihypertensive
Steven M. Smith, Almut G. Winterstein, Matthew J. Gurka, Marta G. Walsh, Shailina Keshwani, Anne M. Libby, William R. Hogan, Carl J. Pepine, Rhonda M. Cooper‐DeHoff   +8 more
doaj   +1 more source